A portfolio with profound benefits for patients and doctors

Our first focus is on ischaemic diseases and peripheral arterial diseases (PAD) such as critical limb ischaemia

Exosome-based therapies to treat serious diseases

Developing proprietary manufacturing technology and processes for high value exosome products

Working with global partners to take Australian innovation to the world

Our highly capable expert team has significant experience in the development and commercialisation of biological therapies


Contact us


Ian Nisbet PhD

Email: ian.nisbet@vivazome.com

Tel: +61 (0)431 709 121

Craig Newton BAppSc, GD Management, GD Marketing

Email: craig.newton@vivazome.com

Tel: +61 (0) 434 674 256